Abstract: An elevated flooring system having plurality of beams configured to support a respective portion of at least one flooring panel, and at least one saddle configured to support the at least one of the beams. The saddle has a generally horizontally oriented base plate with an alignment post extending generally vertically upwardly from the base plate. The beam has an alignment passage extending through a portion of the bottom of a first end of the beam, wherein the alignment passage is configured to receive a portion of the alignment post of the saddle such that a portion of the beam rests on a portion of the base plate. A method of installing the elevated flooring system includes lowering a first beam and a second beam onto the alignment post of a saddle such that respective portions of the alignment post are received by the alignment passage of the first beam and the alignment passage of the second beam.

Abstract: The present disclosure relates to methods of treating organic acidemias with 2.2-dimethylbutyric acid or pharmaceutically acceptable salt thereof.

Abstract: An elevated flooring system having plurality of beams configured to support a respective portion of at least one flooring panel, and at least one saddle configured to support the at least one of the beams. The saddle has a generally horizontally oriented base plate with an alignment post extending generally vertically upwardly from the base plate. The beam has an alignment passage extending through a portion of the bottom of a first end of the beam, wherein the alignment passage is configured to receive a portion of the alignment post of the saddle such that a portion of the beam rests on a portion of the base plate. A method of installing the elevated flooring system includes lowering a first beam and a second beam onto the alignment post of a saddle such that respective portions of the alignment post are received by the alignment passage of the first beam and the alignment passage of the second beam.

Abstract: The invention is directed to purified and isolated novel TSLP polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.